18 stories from 8 sources

Women’s health gets a new federal structure, but impact awaits funding

Day’s Recap

Supporting Articles

4:29 PMAl Jazeera

Trump signs order launching women’s health division at NIH, White House

Summary

Donald Trump signed an executive order creating a women's health division at the National Institutes of Health. First Lady Melania Trump has promoted the action as a major step for women's health in the United States.

The order creates a new federal structure intended to focus NIH research and policy attention

Why it matters

The initiative could redirect federal research resources toward conditions and evidence gaps that have historically received less attention in women's health.

1:42 PMStat News

Trump orders creation of NIH division, task force on women’s health

Summary

Trump ordered the creation of an NIH division and a task force dedicated to women's health research and policy. Melania Trump said the initiative would establish a new standard for women's health.

The administration is creating new federal structures to make women's health a defined research and

Why it matters

New NIH authority could influence which women's health conditions receive federal research attention and money.

1:13 PMFortune

Trump plans new women’s health research division at NIH after push from first lady Melania Trump

Summary

The administration plans to create a new NIH division and a White House task force focused on women’s health research. The proposal does not specify new funding targets.

The initiative creates an institutional focus on women’s health but leaves its practical impact unresolved

Why it matters

A new structure could improve attention to neglected research areas, but without money it may remain largely symbolic.

3 stories · 3 sources

8:57 AMScienceDaily

Why some people escape Alzheimer’s despite carrying a high-risk gene

Summary

Researchers identified a rare mutation that appears to protect some people with a high-risk Alzheimer’s gene from harmful protein buildup and cognitive decline. The discovery may reveal a biological defense that future therapies could reproduce.

The decisive finding is that genetic risk does not act alone: a protective mutation can

Why it matters

A natural protective pathway could provide a new target for Alzheimer’s prevention before irreversible damage occurs.

9:36 AMAl Jazeera

Doctors describe hospitals shattered by Israel’s genocide in Gaza

Summary

Doctors who volunteered in Gaza described working in hospitals damaged and overwhelmed during Israel’s war in the territory. Their accounts focus on the destruction of medical facilities and the conditions facing healthcare workers and patients.

The testimony points to the collapse of hospital capacity as a direct consequence of the

Why it matters

When hospitals lose buildings, staff, and supplies, the damage extends beyond immediate casualties to the territory’s ability to treat illness and injury.

4:30 AMStat News

STAT+: How the No Surprises Act’s nonprofit arbitrators are operating like ‘mini gods’ and getting rich doing it

Summary

A STAT investigation found that several nonprofits serving as arbitrators under the No Surprises Act are collecting large sums while deciding payment disputes. The program was designed to protect patients from surprise medical bills, but the arbitrators' financial incentives and broad discretion are under scrutiny.

The arbitration system may have shifted leverage from surprise-billed patients to intermediaries whose decisions can

Why it matters

A safeguard against surprise bills can still inflate healthcare costs if the dispute-resolution system lacks effective oversight.

4:35 AMStat News

STAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds

Summary

A Gilead Sciences oral treatment eliminated symptoms in patients with a form of inflammatory bowel disease in a mid-stage study. The results offer an early clinical test of the drug's potential as a new treatment option.

The study shifts Gilead's drug from a development concept toward a potentially viable therapy, but

Why it matters

Positive mid-stage data could expand treatment choices for patients with difficult-to-manage bowel disease.

Other Developments

A curated list of other prominent stories from this day.

8:02 PMBBC

US church on front line of battle against drug known as 'tranq'

Summary

Synthetic opioids such as fentanyl have become more potent and widely available, reshaping the drug landscape. A US church is working on the frontline of the response to the drug known as tranq.

The spread of tranq shows how the illicit drug supply is creating needs that conventional

Why it matters

Community institutions are becoming essential partners as a more dangerous and unpredictable drug supply outpaces formal services.

7:11 AMMarketWatch

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

Summary

Deep-vein thrombosis and pulmonary embolism can affect elite athletes, and research suggests treatment may keep them out of competition for more than six months. The risk is not limited to older or less active people.

A blood clot can impose a long recovery even when the patient is young, highly

Why it matters

Blood clots can disrupt elite careers and require prolonged risk management, not just short-term treatment.

8:03 AMScienceDaily

Scientists discover why some people still can’t taste food after COVID-19

Summary

Researchers found molecular abnormalities in the taste buds of people who continued to experience taste loss more than a year after COVID-19. These changes appear to weaken signals for sweet, bitter, and savory flavors.

The findings move persistent post-COVID taste loss from a largely unexplained symptom toward a specific

Why it matters

Identifying damaged taste signaling may help clinicians distinguish persistent biological injury from temporary sensory disruption.

7:23 AMScienceDaily

Just 3,000 steps a day may help slow Alzheimer's, scientists find

Summary

New research links walking at least 3,000 steps a day with less tau buildup and roughly half the cognitive and functional decline in people showing early signs of Alzheimer’s. The strongest association appeared among those taking 5,000 to 7,500 steps daily, below the commonly promoted 10,000-step target.

The key shift is that modest activity may correlate with slower disease progression, even after

Why it matters

A lower daily step target could make brain-health advice more practical for older adults at risk.

6:30 AMGothamist

Need help with mental health or addiction services? NYC has a new tool.

Summary

New York City has launched a tool to help residents find mental health and addiction services. It addresses a common barrier: many people who want care do not know where to begin.

The city is trying to reduce the first-step problem in behavioral health by making service

Why it matters

Easier navigation can convert unmet demand for behavioral health care into actual treatment.

5:19 AMScienceDaily

"Mind-blowing" Alzheimer’s breakthrough: Two hours of sleep restored without clearing brain plaques

Summary

In mice, researchers restored more than two hours of daily sleep by temporarily removing overactive immune cells in the brain. The result suggests that Alzheimer’s-related sleep disruption can improve without removing the disease’s characteristic plaques.

The important shift is therapeutic: sleep loss may be driven partly by inflammatory brain cells,

Why it matters

A treatment aimed at brain inflammation could address a debilitating Alzheimer’s symptom without requiring plaque clearance.

4:30 AMStat News

STAT+: Top immunology association divided over $8.4-billion California ballot measure to fund the field, emails show

Summary

Internal emails show that the American Association of Immunologists is divided over California Proposition 38, which would direct $8.4 billion in taxpayer funding to immunology. The dispute exposes disagreement within the field over a major public investment.

The split means the measure faces not only a political test but also a credibility

Why it matters

A large public research program can become harder to defend when its intended beneficiaries cannot agree on it.

4:30 AMStat News

Opinion: Measles is back — and becoming a midterm liability for Republicans

Summary

Physicians and former Republican lawmakers argue that the resurgence of measles is becoming a political liability for Republicans who remain silent on vaccination. They contend that vaccine positions could alienate voters who otherwise support the party.

Measles outbreaks are turning vaccine policy from a public-health issue into a clear electoral exposure.

Why it matters

A preventable disease outbreak is creating political costs for candidates who avoid taking a clear position on vaccines.

4:30 AMStat News

Opinion: My mother killed herself. I wish assisted suicide had been an option

Summary

In a personal essay, Torie Bosch argues that assisted suicide should be considered for some people with severe mental illness, drawing on her mother's suicide. The essay challenges the assumption that medical aid in dying should be limited to physical illnesses.

Including psychiatric conditions would widen the eligibility debate and force policymakers to define when mental

Why it matters

The argument tests the boundaries of assisted dying laws and the safeguards built around them.

4:30 AMStat News

STAT+: Does Isomorphic Labs have what it takes to revolutionize drugmaking?

Summary

Isomorphic Labs is trying to turn its technology into a platform for discovering new medicines. Its central challenge is proving that the technology can produce effective drugs, not merely promising computational predictions.

The company is moving from artificial intelligence's promise to the harder test of clinical validation.

Why it matters

AI will reshape drug development only if it improves outcomes in the costly, failure-prone stages after discovery.

4:00 AMPYMNTS

Why Insured Workers Still Skip Healthcare

Summary

Many insured adults still avoid needed care because medical bills can trigger credit checks or become unaffordable. The article argues that employers track premiums but rarely measure the cost of delayed or forgone treatment.

Insurance has not removed the financial barriers that keep workers from seeking care. Employees face

Why it matters

Coverage can look adequate on paper while leaving workers unable to use it.

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!